№ lp_1_2_25747
File format: docx
Character count: 34075
File size: 114 KB
The protocol provides a standardized framework for submitting study protocols to the VU HRPP, including sections for research objectives, procedures, data management, and participant consent.
Note:
Year
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Note:
Year
Year:
2024
Region / city:
Edinburgh, UK
Topic:
Genetics of Mortality in Critical Care
Document Type:
Study Protocol
Organization / Institution:
University of Edinburgh, NHS Lothian Health Board
Author:
Prof JK Baillie, Ms F Griffiths, Dr S Clohisey, Dr A Law, Dr N Parkinson, Mr L Murphy, Mr Edward Rippingale-Combes
Target Audience:
Researchers, Healthcare professionals
Duration:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
Not specified
Region / City:
Cincinnati
Subject:
Social and Behavioral Sciences Research
Document Type:
Research Protocol Submission Guidelines
Institution / Organization:
University of Cincinnati
Author:
Not specified
Target Audience:
Researchers submitting to the IRB-S
Validity Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
United States
Theme:
Racial and gender discrimination, military climate, sexual harassment, sexual assault
Document Type:
Research Protocol
Organization / Institution:
Department of Defense, Office of People Analytics (OPA)
Author:
Unknown
Target Audience:
Racial/ethnic minority service members in the U.S. military
Period of Action:
2023
Approval Date:
Unknown
Date of Changes:
Unknown
Version:
1.5.0.0
Protocol Posting Date:
June 2024
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2025
Authors:
Gulisa Turashvili, MD, PhD; Uma G. Krishnamurti, MD, PhD; Barbara A. Crothers, DO; Giovanna A. Giannico, MD; Krisztina Hanley, MD; Anna Plotkin, MD; Anthony N. Karnezis, MD, PhD.
Note:
Accreditation Requirements
Date of Protocol Posting:
June 2024
Date of Required Use:
March 2025
Year:
2025
Date:
September 11, 2025
Version:
v1.1
Document type:
Research report
Author:
Edgar Marcelo Quiroz Robles
Affiliation:
Independent Researcher
Field:
Theoretical cosmology and mathematical physics
Framework:
4-Dimensional Elastic Model of the Universe (4DEM)
Related theories:
String theory
Status:
Draft
Repository:
Zenodo
Publication note:
Extended appendices published as Amazon KDP eBooks
Note:
Year
Year:
2026
Version:
NENC v2.0
Date published:
22 January 2026
Planned review date:
October 2027
Region:
North East and North Cumbria
Healthcare system:
NHS
Clinical area:
Neurology
Condition:
Amyotrophic lateral sclerosis
Medicine:
Riluzole
Document type:
Shared care protocol
Indication:
Extension of survival or time to mechanical ventilation in ALS
Target population:
Adults
Intended audience:
NHS healthcare professionals
Initiating authority:
Neurological specialist services
Regulatory reference:
NICE Technology Appraisal TA20
Prescribing setting:
Secondary to primary care transfer
Monitoring requirements:
Liver function tests, full blood count, urea and electrolytes
Route of administration:
Oral or enteral
Licensing status:
Licensed for ALS only
Investigator:
[insert name of principal investigator]
Key Information:
The following is a short summary of this study to help you decide whether or not to be a part of this study. More detailed information is listed later on in this form.
Note:
Why am I being invited to take part in a research study?
You will be asked to _________ [include a high level summary of the procedures that will be done. For example:
You will be given an investigational drug and asked to come for 3 study visits. You will give a total of 3 blood samples and fill out questionnaires asking about how you feel.]
Instead of being in this research study, your choices may include:
[List alternatives procedures. For student subject pools describe alternatives for course credit. For clinical trials describe the options that you would normally offer patient. If applicable, include supportive care as an option.]
Detailed Information:
The following is more detailed information about this study in addition to the information listed above.
[Tell the subject what to expect using lay language and simple terms. Whenever appropriate include the following items:
]
Year:
2020
Type of Document:
Protocol
Organization:
XXXX
Target Audience:
Leadership, Crisis Management Team
Scope:
International
Update Date:
October 2020
Document Sections:
Definitions, Purpose, Crisis Management Team, Escalation Levels, Phases, Strategy, Logs, After-Action Review, Annexures
Note:
Year
Year:
2025
Region / City:
London
Topic:
Neonatal BCG vaccination program
Document Type:
Protocol
Organization / Institution:
NHSE
Author:
Alice Waters
Target Audience:
Healthcare professionals involved in neonatal care and immunization
Period of validity:
Not specified
Approval Date:
Not specified
Date of changes:
September 2025
Year:
2022
Region / City:
Cheshire and Merseyside
Subject:
Child Protection, Family Law
Document Type:
Practice Note
Issuing Authority:
His Honour Judge Steven Parker, Designated Family Judge for Cheshire and Merseyside
Period of Application:
2022-2023 (pilot phase)
Approval Date:
9th March 2022
Amendment Date:
None
Note:
Date of Application
Year:
2025
Region / city:
United Kingdom
Subject:
COVID-19 vaccination
Document type:
Protocol
Institution:
UK Health Security Agency (UKHSA)
Author:
UK Health Security Agency (UKHSA)
Target audience:
Healthcare providers involved in COVID-19 vaccination
Period of validity:
1 October 2025 – 31 January 2026
Approval date:
12 September 2025
Note:
Revision history
Note:
Year
Subject:
Solar Energy, Photovoltaic Systems
Document Type:
Technical Plan
Target Audience:
Contractors, Engineers
Context:
Technical source document outlining standard plans for solar PV system installations for residential properties.
Document type:
Standard procurement document
Subject:
Procurement of non-consulting services
Issuing organization:
The World Bank
Financing institutions:
International Bank for Reconstruction and Development; International Development Association
Procurement method:
International competitive procurement
Procurement process:
Request for Bids
Applicable regulations:
Procurement Regulations for IPF Borrowers (July 2016, as amended)
Contract type:
Lump-sum contract
Initial publication year:
2002
Revision dates:
December 2002; April 2007; July 2016; January 2017; October 2017
Geographic scope:
International
Copyright status:
Copyrighted; non-commercial use permitted
Intended users:
Borrowers and implementing agencies of World Bank–financed projects
Jurisdiction:
Commonwealth of Massachusetts
Year:
2016
Update date:
July 2016
Document type:
Application form
Purpose:
Designer qualification and submission for public projects
Applicable entities:
Municipalities and public agencies not within DSB jurisdiction
Issuing authority:
Commonwealth of Massachusetts
Subject matter:
Public procurement, designer selection
Intended applicants:
Design firms and joint ventures
Regulatory context:
Massachusetts public design and construction procurement